MoneyWorks4Me

Aurobindo Pharma informs about disclosure

01 Sep 2026 Evaluate

Aurobindo Pharma has informed that, Pharma Private, a wholly owned subsidiary of the Company has incorporated a new wholly owned subsidiary by the name of ‘Avogent Lifesciences’ in India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1683.00 -7.00 (-0.41%)
01-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1930.45
Dr. Reddys Labs. 1171.00
Cipla 1418.00
Lupin 2150.00
Zydus Lifesciences 1164.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: